|
|
Blood, 1 September 2004, Vol. 104, No. 5, pp. 1273-1280.
Prepublished online as a Blood First Edition Paper on May 4, 2004; DOI 10.1182/blood-2003-08-2935.
 Previous Article | Table of Contents | Next Article 
GENE THERAPY
The impact of low-dose busulfan on clonal dynamics in nonhuman primates
Ken Kuramoto,
Dean Follman,
Peiman Hematti,
Stephanie Sellers,
Mikko O. Laukkanen,
Ruth Seggewiss,
Mark E. Metzger,
Allen Krouse,
Robert E. Donahue,
Christof von Kalle, and
Cynthia E. Dunbar
From the Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD; the Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD; and the Division of Experimental Hematology, Children's Research Foundation, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
An understanding of the number and contribution of individual pluripotent hematopoietic stem cells (HSCs) to the formation of blood lineages has important clinical implications for gene therapy and stem cell transplantation. We have been able to efficiently mark rhesus macaque long-term repopulating stem and progenitor cells with retroviral vectors, and track their in vivo contributions to hematopoiesis using the linear amplification mediated–polymerase chain reaction (LAM-PCR) technique of insertion site analysis. We assessed the impact of busulfan on contributions of individual retrovirally marked clones to hematopoiesis. There were 2 macaques that received transplants of retrovirally transduced CD34+ cells 2 years previously that were then treated with 4 mg/kg busulfan. Despite only transient and mild suppression of peripheral blood counts, the numbers of individual stem/progenitor clones contributing to granulocyte production decreased dramatically, by 80% in the first monkey and by 60% in the second monkey. A similar impact was seen on clones contributing to T cells. The clone numbers recovered gradually back toward baseline by 5 months following busulfan in the first monkey and by 3 months in the second monkey, and have remained stable for more than one year in both animals. Tracking of individual clones with insertion-site–specific primers suggested that clones contributing to hematopoiesis prior to busulfan accounted for the majority of this recovery, but that some previously undetected clones began to contribute during this recovery phase. These results indicate that even low-dose busulfan significantly affects stem and progenitor cell dynamics. The clonal diversity of hematopoiesis was significantly decreased after even a single, clinically well-tolerated dose of busulfan, with slow but almost complete recovery over the next several months, suggesting that true long-term repopulating stem cells were not permanently deleted. However, the prolonged period of suppression of many clones suggests that transplanted HSCs may have a marked competitive advantage if they can engraft and proliferate during this time period, and supports the use of this agent in nonmyeloablative regimens
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
I. B. Enquist, E. Nilsson, J.-E. Mansson, M. Ehinger, J. Richter, and S. Karlsson
Successful Low-Risk Hematopoietic Cell Therapy in a Mouse Model of Type 1 Gaucher Disease
Stem Cells,
March 1, 2009;
27(3):
744 - 752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Hayakawa, M. M. Hsieh, N. Uchida, O. Phang, and J. F. Tisdale
Busulfan Produces Efficient Human Cell Engraftment in NOD/LtSz-Scid IL2R{gamma}Null Mice
Stem Cells,
January 1, 2009;
27(1):
175 - 182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yahata, Y. Muguruma, S. Yumino, Y. Sheng, T. Uno, H. Matsuzawa, M. Ito, S. Kato, T. Hotta, and K. Ando
Quiescent Human Hematopoietic Stem Cells in the Bone Marrow Niches Organize the Hierarchical Structure of Hematopoiesis
Stem Cells,
December 1, 2008;
26(12):
3228 - 3236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Hermann, M. Sukhwani, C.-C. Lin, Y. Sheng, J. Tomko, M. Rodriguez, J. J. Shuttleworth, D. McFarland, R. M. Hobbs, P. P. Pandolfi, et al.
Characterization, Cryopreservation, and Ablation of Spermatogonial Stem Cells in Adult Rhesus Macaques
Stem Cells,
September 1, 2007;
25(9):
2330 - 2338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. R. Bauer Jr, M. Hai, L. M. Tuschong, T. H. Burkholder, Y.-c. Gu, R. A. Sokolic, C. Ferguson, C. E. Dunbar, and D. D. Hickstein
Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy
Blood,
November 15, 2006;
108(10):
3313 - 3320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. O. Laukkanen, K. Kuramoto, B. Calmels, M. Takatoku, C. von Kalle, R. E. Donahue, and C. E. Dunbar
Low-dose total body irradiation causes clonal fluctuation of primate hematopoietic stem and progenitor cells
Blood,
February 1, 2005;
105(3):
1010 - 1015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
